In this review, we analyzed the PBG and PI data via the iAUC, potentially masking any significant differences at specific time points (e.g., first-phase insulin response), which could be informative of metabolic disease progression for subjects with or at risk of T2D. This evidence concerns the gene INS and metabolic disease.